BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cytognos, S.L. - ECPv4.9.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cytognos, S.L.
X-ORIGINAL-URL:https://www.cytognos.com
X-WR-CALDESC:Events for Cytognos, S.L.
BEGIN:VTIMEZONE
TZID:"Europe/Paris"
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210414
DTEND;VALUE=DATE:20210418
DTSTAMP:20260425T202121
CREATED:20210204T123444Z
LAST-MODIFIED:20210415T114709Z
UID:15770-1618358400-1618703999@www.cytognos.com
SUMMARY:CIS 2021 Virtual Annual Meeting
DESCRIPTION:\n					\n						Clinical Immunology Flow Cytometry solutions by Cytognos:\nCytognos is a clinical flow cytometry company providing solutions for Primary Immunodeficiencies and Immunemonitoring that help in standardizing your laboratory practice while improving patient care. \n\n\n					\n				\n					\n						@media only screen and (max-width:800px) {.fusion-title.fusion-title-1{margin-top:0px!important;margin-bottom:10px!important;}}Response to Covid-19Cytognos is providing diagnostic and research flow cytometry tools to get the full picture of the immune status of the patient and to study the immune response to vaccine antigens. \n\n\n					\n				\n					\n						@media only screen and (max-width:800px) {.fusion-title.fusion-title-2{margin-top:0px!important;margin-bottom:10px!important;}}Primary immunodeficiencies (PID)PIDOT kit for Screening \nIn the diagnostic workup of patients suspected of PID\, an accurate flow cytometry immunophenotyping is essential for guiding further functional and genetic testing. \nCytognos offers a highly sensitive Screening test for Primary Immunodeficiencies coupled with normal control values from newborns to elderly age groups for a reproducible and sensitive detection of all the lymphoid immunodeficiencies (B-\, T- and NK-). \nIt has been validated  on 250 healthy controls and 99 PID patients with defined genetic defects by the EuroFlow™ group – EuroFlow™ is an independent scientific foundation focused on Primary Immunodeficiencies and Immune Monitoring applications by flow cytometry. \nCheck out the publication supporting the use of this method here. \nCheck out what our customers are saying about the evaluation of Primary Immunodeficiencies by our Next Generation Flow (NGF) approach: \nThe role of Flow Cytometry in the laboratory approach of Primary Immunodeficiency\nCatarina Martins\, PhD \n \nIg subclasses kit for B cell characterization \nTo help you identify selective IgA deficiencies\, IgH subclass deficiencies and various types of CVID\, Cytognos offers the IgH-isotype B-cell reagent kit coupled with a database of normal B and plasma cells reference ranges by 13 different age groups validated by EuroFlow™. \nThis approach allows you to detect B cell maturation changes at cellular level\, overcoming the challenges of serum blood testing in patients treated with hyperimmune plasma. \nCheck out the publication describing the age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood here. \n\n\n					\n				\n					\n						Contact info:\nIrene González – Key Account Manager\, East Coast (US) and Canada – igonzalez@cytognos.com \n\n\n					\n				 \n
URL:https://www.cytognos.com/event/cis-2021/
CATEGORIES:Congresses and Meetings
ATTACH;FMTTYPE=image/jpeg:https://www.cytognos.com/wp-content/uploads/CIS-2021-min.jpg
END:VEVENT
END:VCALENDAR